Nanotech to be trialled in upcoming therapeutic trial for cancer
After multiple successful clinical trials, nanotech Cornell dots are being used for their first therapeutic trial to fight cancer.
Source: tweaktown.com
Cornell Dots News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cornell Dots. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cornell Dots Today - Breaking & Trending Today
Prime time: First therapeutic clinical trial of C'Dots underway
C’Dots, silica-encased nanoparticles developed in the lab of engineering professor Ulrich Wiesner, have just begun their first therapeutic human clinical trial. They’re being further developed by Elucida Oncology Inc., a company co-founded by Wiesner.
Source: cornell.edu